Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 41, 2014, Pages E4359-E4366

  Latimer, Caitlin S ^a,c   Brewer, Lawrence D ^a   Searcy, James L ^a,d   Chen, Kuey Chu ^a   Popović, Jelena ^a   Kraner, Susan D ^b   Thibault, Olivier ^a   Blalock, Eric M ^a   Landfield, Philip W ^a   Porter, Nada M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

25 hydroxyvitamin D; Cholecalciferol; Vitamin D status

Indexed keywords

VITAMIN D;

AGING; ANIMAL; BIOLOGICAL MODEL; BLOOD; COGNITION DISORDERS; COMPUTER PROGRAM; DIET; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; FISCHER 344 RAT; GENETICS; HIPPOCAMPUS; HUMAN; MALE; MAZE TEST; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SYNAPTIC TRANSMISSION; UPREGULATION;

AGING; ANIMALS; COGNITION DISORDERS; DIET; HIPPOCAMPUS; HUMANS; MALE; MAZE LEARNING; MODELS, NEUROLOGICAL; NEURONS; RATS, INBRED F344; RESPONSE ELEMENTS; SOFTWARE; SYNAPTIC TRANSMISSION; UP-REGULATION; VITAMIN D;

EID: 84907898956     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1404477111     Document Type: Article

References (97)

1. Plum LA, DeLuca HF (2010) Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9(12):941-955.
2. Christakos S, DeLuca HF (2011) Minireview: Vitamin D: Is there a role in extraskeletal health? Endocrinology 152(8):2930-2936.
3. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266-281.
4. Buell JS, et al. (2010) 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74(1):18-26.
5. Hossein-nezhad A, Holick MF (2013) Vitamin D for health: A global perspective. Mayo Clin Proc 88(7):720-755.
6. Timpini A, Pini L, Tantucci C, Cossi S, Grassi V (2011) Vitamin D and health status in elderly. Intern Emerg Med 6(1):11-21.
7. Heaney RP (2008) Vitamin D in health and disease. Clin J Am Soc Nephrol 3(5):1535-1541.
8. Kojima G, et al. (2012) Low dietary vitamin D predicts 34-year incident stroke: The Honolulu Heart Program. Stroke 43(8):2163-2167.
9. Bouillon R, et al. (2014) Vitamin D and energy homeostasis - Of mice and men. Nat Rev Endocrinol 10(2):79-87.
10. Fleet JC, DeSmet M, Johnson R, Li Y (2012) Vitamin D and cancer: A review of molecular mechanisms. Biochem J 441(1):61-76.
11. Llewellyn DJ, Langa KM, Lang IA (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22(3):188-195.
12. Annweiler C, et al. (2010) Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study. Neurology 74(1):27-32.
13. Llewellyn DJ, et al. (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170(13):1135-1141.
14. Slinin Y, et al.; Study of Osteoporotic Fractures Research Group (2012) Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 67(10):1092-1098.
15. Cui X, Groves NJ, Burne TH, Eyles DW, McGrath JJ (2013) Low vitamin D concentration exacerbates adult brain dysfunction. Am J Clin Nutr 97(5):907-908.
16. Przybelski RJ, Binkley NC (2007) Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460(2):202-205.
17. Annweiler C, Herrmann FR, Fantino B, Brugg B, Beauchet O (2012) Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: A pre-post pilot study. Cogn Behav Neurol 25(3):121-127.
18. Stumpf WE, O'Brien LP (1987) 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 87(5):393-406.
19. Langub MC, Herman JP, Malluche HH, Koszewski NJ (2001) Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience 104(1):49-56.
20. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100-105.
21. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29(1):21-30.
22. Eyles DW, Liu PY, Josh P, Cui X (2014) Intracellular distribution of the vitamin D receptor in the brain: Comparison with classic target tissues and redistribution with development. Neuroscience 268:1-9.
23. Landfield PW, Cadwallader-Neal L (1998) Long-term treatment with calcitriol (1,25 (OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging 19(5):469-477.
24. Brewer LD, et al. (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21(1):98-108.
25. Wang JY, et al. (2001) Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 904(1):67-75.
26. Moore ME, Piazza A, McCartney Y, Lynch MA (2005) Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans 33(Pt 4):573-577.
27. Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O (2006) Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging. Cell Calcium 40(3):277-286.
28. Acosta S, et al. (2010) NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat. Rejuvenation Res 13(5):581-588.
29. Vincent GK, Velkoff VA; US Census Bureau (2010) The Next Four Decades: The Older Population in the United States: 2010 to 2050 (US Department of Commerce, Economics, and Statistics Administration, US Census Bureau, Washington, DC), pp. 1-14.
30. McCann JC, Ames BN (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22(4):982-1001.
31. Blalock EM, et al. (2003) Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23(9):3807-3819.
32. Lynch G, Rex CS, Gall CM (2006) Synaptic plasticity in early aging. Ageing Res Rev 5(3):255-280.
33. Finch CE (2009) The neurobiology of middle-age has arrived. Neurobiol Aging 30(4):515-520, discussion 530-533.
34. Kadish I, et al. (2009) Hippocampal and cognitive aging across the lifespan: A bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J Neurosci 29(6):1805-1816.
35. Keeney JT, et al. (2013) Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: Implications for low vitamin D-dependent age-related cognitive decline. Free Radic Biol Med 65:324-334.
36. Eyles D, et al. (2009) A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta 403(1-2):145-151.
37. Newman MS, et al. (2009) A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: A potential adjunct to diabetes and cardiometabolic risk screening. J Diabetes Sci Tech 3(1):156-162.
38. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9(7):811-818.
39. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57.
40. Mirnics K, Pevsner J (2004) Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 7(5):434-439.
41. Rowe WB, et al. (2007) Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 27(12):3098-3110.
42. Gene Ontology Consortium (2010) The Gene Ontology in 2010: Extensions and refinements. Nucleic Acids Res 38(Database issue):D331-D335.
43. Pike JW, Meyer MB (2014) Fundamentals of vitamin D hormone-regulated gene expression. J Steroid Biochem Mol Biol 144PA:5-11.
44. Burke SN, Barnes CA (2010) Senescent synapses and hippocampal circuit dynamics. Trends Neurosci 33(3):153-161.
45. Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85(1):6-18.
46. Vorhees CV, Williams MT (2006) Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1(2):848-858.
47. Bartsch T, et al. (2010) Focal lesions of human hippocampal CA1 neurons in transient global amnesia impair place memory. Science 328(5984):1412-1415.
48. Foster TC, Defazio RA, Bizon JL (2012) Characterizing cognitive aging of spatial and contextual memory in animal models. Front Aging Neurosci 4:12.
49. Buzsáki G, Moser EI (2013) Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nat Neurosci 16(2):130-138.
50. Moser MB, Moser EI, Forrest E, Andersen P, Morris RG (1995) Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci USA 92(21):9697-9701.
51. D'Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36(1):60-90.
52. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation. Annu Rev Neurosci 32:267-287.
53. Salthouse TA (1996) The processing-speed theory of adult age differences in cognition. Psychol Rev 103(3):403-428.
54. Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7(1):30-40.
55. Landfield PW, McGaugh JL, Lynch G (1978) Impaired synaptic potentiation processes in the hippocampus of aged, memory-deficient rats. Brain Res 150(1):85-101.
56. Norris CM, Korol DL, Foster TC (1996) Increased susceptibility to induction of long-term depression and long-term potentiation reversal during aging. J Neurosci 16(17):5382-5392.
57. Disterhoft JF, Oh MM (2007) Alterations in intrinsic neuronal excitability during normal aging. Aging Cell 6(3):327-336.
58. Kumar A, Foster TC (2007) Neurophysiology of old neurons and synapses. Brain Aging: Models, Methods, and Mechanisms, Frontiers in Neuroscience, ed Riddle DR (CRC Press, Boca Raton, FL).
59. Applegate MD, Landfield PW (1988) Synaptic vesicle redistribution during hippocampal frequency potentiation and depression in young and aged rats. J Neurosci 8(4):1096-1111.
60. deToledo-Morrell L, Geinisman Y, Morrell F (1988) Age-dependent alterations in hippocampal synaptic plasticity: Relation to memory disorders. Neurobiol Aging 9(5-6):581-590.
61. Berchtold NC, et al. (2013) Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging 34(6):1653-1661.
62. Wenk MR, De Camilli P (2004) Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: Insights from vesicle recycling in nerve terminals. Proc Natl Acad Sci USA 101(22):8262-8269.
63. Südhof TC (2013) A molecular machine for neurotransmitter release: Synaptotagmin and beyond. Nat Med 19(10):1227-1231.
64. Fremeau RT, Jr, et al. (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31(2):247-260.
65. Takamori S, et al. (2006) Molecular anatomy of a trafficking organelle. Cell 127(4):831-846.
66. Lee YS, Silva AJ (2009) The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci 10(2):126-140.
67. Mouravlev A, Dunning J, Young D, During MJ (2006) Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats. Proc Natl Acad Sci USA 103(12):4705-4710.
68. Morris KA, Gold PE (2012) Age-related impairments in memory and in CREB and pCREB expression in hippocampus and amygdala following inhibitory avoidance training. Mech Ageing Dev 133(5):291-299.
69. Hawk JD, et al. (2012) NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. J Clin Invest 122(10):3593-3602.
70. Fleet JC, et al. (2008) Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J Nutr 138(6):1114-1120.
71. Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: Minding the store. Aging Cell 6(3):307-317.
72. Gemma C, Vila J, Bachstetter A, Bickford PC (2007) Oxidative stress and the aging brain: From theory to prevention. Brain Aging: Models, Methods, and Mechanisms, Frontiers in Neuroscience, ed Riddle DR (CRC Press, Boca Raton, FL).
73. Brinton RD (2008) The healthy cell bias of estrogen action: Mitochondrial bioenergetics and neurological implications. Trends Neurosci 31(10):529-537.
74. Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229(11):1136-1142.
75. Boyle MET, et al. (2001) Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30(2):385-397.
76. Shimazaki K, Hosoya H, Takeda Y, Kobayashi S, Watanabe K (1998) Age-related decline of F3/contactin in rat hippocampus. Neurosci Lett 245(2):117-120.
77. Shepherd MN, Pomicter AD, Velazco CS, Henderson SC, Dupree JL (2012) Paranodal reorganization results in the depletion of transverse bands in the aged central nervous system. Neurobiol Aging 33(1):e13-e24.
78. Lu PH, et al. (2011) Age-related slowing in cognitive processing speed is associated with myelin integrity in a very healthy elderly sample. J Clin Exp Neuropsychol 33(10):1059-1068.
79. Peters A, Kemper T (2012) A review of the structural alterations in the cerebral hemispheres of the aging rhesus monkey. Neurobiol Aging 33(10):2357-2372.
80. Puzzo D, et al. (2013) F3/Contactin promotes hippocampal neurogenesis, synaptic plasticity, and memory in adult mice. Hippocampus 23(12):1367-1382.
81. Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG (2013) Threats to validity in the design and conduct of preclinical efficacy studies: A systematic review of guidelines for in vivo animal experiments. PLoS Med 10(7):e1001489.
82. Salthouse TA (2009) When does age-related cognitive decline begin? Neurobiol Aging 30(4):507-514.
83. Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for north america: Clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79-84.
84. Rosen CJ, et al. (2012) IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97(4):1146-1152.
85. Dawson-Hughes B, et al. (2010) IOF position statement: Vitamin D recommendations for older adults. Osteoporos Int 21(7):1151-1154.
86. Norman AW, Bouillon R (2010) Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 235(9):1034-1045.
87. Holick MF, et al.; Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911-1930.
88. Heaney RP (2013) Health is better at serum 25(OH)D above 30ng/mL. J Steroid Biochem Mol Biol 136:224-228.
89. Ross AC, et al. (2011) The 2011 Dietary Reference Intakes for Calcium and Vitamin D: What dietetics practitioners need to know. J Am Diet Assoc 111(4):524-527.
90. Balden R, Selvamani A, Sohrabji F (2012) Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology 153(5):2420-2435.
91. Eyles DW, Burne TH, McGrath JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34(1):47-64.
92. Berridge MJ (2013) Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 7(1):2-13.
93. Kupferschmidt K (2012) Uncertain verdict as vitamin D goes on trial. Science 337(6101):1476-1478.
94. Sperling RA, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3):280-292.
95. Goldman DP, et al. (2013) Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 32(10):1698-1705.
96. Blalock EM, et al. (2010) Effects of long-term pioglitazone treatment on peripheral and central markers of aging. PLoS ONE 5(4):e10405.
97. Zhu JG, Ochalek JT, Kaufmann M, Jones G, Deluca HF (2013) CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci USA 110(39):15650-15655.